Selling And Administration Expenses Perubahan Tanggal
AbbVie USD 3.61B 273M 2023-12
Acorda Therapeutics USD 21.82M 689K 2023-06
Amgen USD 1.76B 424M 2023-12
Arrowhead Research USD 26.19M 595K 2023-12
AstraZeneca USD 3.91B 194M 2023-09
BioCryst Pharmaceuticals USD 50.65M 349K 2023-09
Biogen USD 608.5M 179.7M 2023-12
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Enanta Pharmaceuticals USD 13.8M 1.18M 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Heron Therapeutics USD 24.6M 11.84M 2023-09
Immunic USD 3.77M 75K 2023-09
Incyte USD 293.86M 25.97M 2023-12
Insmed USD 89.53M 1.1M 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
J&J USD 5.81B 410M 2023-12
Ligand Pharmaceuticals USD 15.99M 1.34M 2023-12
Marinus Pharmaceuticals USD 14.87M 854K 2023-09
Merck USD 2.75B 272M 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Novavax USD 107.46M 25.24M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
PTC Therapeutics USD 76.29M 4.6M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Enanta Pharmaceuticals Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Mar 2024.